Related Experiment Video
Updated: Dec 25, 2025
09:31
Assessing Replication and Beta Cell Function in Adenovirally-transduced Isolated Rodent Islets
Published on: June 25, 2012
14.3K
Alpha1-antitrypsin ameliorates islet amyloid-induced glucose intolerance and β-cell dysfunction
Júlia Rodríguez-Comas1, Juan Moreno-Vedia1, Mercè Obach1
1Diabetes and Obesity Research Laboratory, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Molecular Metabolism
|April 2, 2020
Summary
Alpha1-antitrypsin (AAT) treatment improved glucose tolerance and insulin secretion in mice with pancreatic beta-cell dysfunction. AAT protected beta-cells from human islet amyloid polypeptide (hIAPP)-induced damage, suggesting AAT as a potential therapy for type 2 diabetes.
Area of Science:
- Endocrinology
- Cell Biology
- Immunology
Background:
- Pancreatic beta-cell failure is a key factor in type 2 diabetes (T2D) pathogenesis.
- Human islet amyloid polypeptide (hIAPP) aggregation contributes to T2D by causing islet inflammation and dysfunction.
- Alpha1-antitrypsin (AAT) possesses anti-inflammatory properties and may offer therapeutic benefits.
Purpose of the Study:
- To investigate the therapeutic potential of AAT in a mouse model of hIAPP-induced beta-cell dysfunction.
- To assess AAT's effects on glucose homeostasis, insulin secretion, and beta-cell survival in the context of hIAPP overexpression.
Main Methods:
- Utilized hIAPP-overexpressing (hIAPP-Tg) mice as a model for amyloid-induced beta-cell dysfunction.
- Evaluated glucose homeostasis via glucose tolerance tests and insulin secretion assays.
- Assessed islet apoptosis, amyloid formation, and macrophage-islet cell cocultures with and without AAT treatment.
Main Results:
- AAT treatment improved glucose tolerance and insulin secretion in hIAPP-Tg mice.
- AAT normalized key beta-cell gene expression (MafA, Pdx1) and prevented hIAPP-induced amyloid formation and apoptosis.
- AAT protected beta-cells from macrophage-mediated cytotoxicity and inflammatory cytokines without inhibiting IL-1β secretion.
Conclusions:
- AAT treatment effectively improves glucose homeostasis and protects pancreatic beta-cells in a model of hIAPP overexpression.
- AAT mitigates hIAPP-induced beta-cell damage, particularly that mediated by macrophages.
- These findings support the development of AAT-based therapies for restoring beta-cell function in type 2 diabetes.
Related Concept Videos
01:27Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
2.0K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
2.0K
01:23Dipeptidyl Peptidase 4 Inhibitors
487
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
487
01:24Glucagon-like Receptor Agonists
757
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
757
01:16Hormones Regulating Blood Glucose
6.1K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
6.1K
01:25Insulin: Biosynthesis, Chemistry, and Preparation
1.1K
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
1.1K
01:22Diabetes Mellitus: Overview and Type I Subtype
4.7K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.7K